Cefpodoxime in Enteric Fever

Current Treatment Recommendations for Enteric Fever

The World Health Organization recommends fluoroquinolones (ciprofloxacin, ofloxacin) as first-line treatment for fully sensitive Salmonella typhi 1, 2
In areas with high fluoroquinolone resistance, azithromycin is recommended as first-line therapy with lower risk of clinical failure (OR 0.48) and shorter hospital stays compared to fluoroquinolones 1, 2, 3
For parenteral therapy, ceftriaxone at 50-80 mg/kg/day (maximum 2g/day) for 5-7 days is recommended for severe cases or when oral therapy is not possible 4

Cefpodoxime is not specifically mentioned in current WHO guidelines for enteric fever treatment 1, 2, 5

Local susceptibility patterns should guide therapy choice, as resistance patterns vary geographically and are changing over time 3

Obtain blood cultures before initiating antibiotics whenever possible 4
Consider local resistance patterns and travel history when selecting empiric therapy 3
For mild to moderate cases, use azithromycin 20 mg/kg/day (maximum 1g/day) for 7 days in areas with high fluoroquinolone resistance 3
For severe cases requiring hospitalization, initiate ceftriaxone 50-80 mg/kg/day (maximum 2g/day) intravenously 4

For patients with clinical features of sepsis, broad-spectrum antimicrobial therapy should be started immediately after blood, stool, and urine culture collection, as recommended by the Infectious Diseases Society of America 6
Treatment should be modified based on antimicrobial susceptibility testing results when available, according to the Clinical Infectious Diseases guidelines 6